Novartis Whistleblower Scores $109M For Flagging Kickbacks

Law360 (July 22, 2020, 4:24 PM EDT) -- The former Novartis Pharmaceuticals Corp. sales representative who blew the whistle on the Swiss drugmaker's alleged scheme to pump up prescriptions through kickbacks will get $109 million plus a share of the interest paid in a $629.8 million False Claims Act settlement approved this month.

U.S. District Judge Paul G. Gardephe on Tuesday signed off on a stipulation that allocated $109.4 million to Oswald Bilotta following the deal in which Novartis agreed to pay $629.8 million to the federal government — including $38.4 million under the Civil Asset Forfeiture Statute.

"We are pleased that the court has approved the award to Mr....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!